Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is MELA Sciences Inc (MELA) A Good Stock To Buy?

Page 1 of 2

Is MELA Sciences Inc (NASDAQ:MELA) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial expertise to work. The top picks of these firms have historically outperformed the market when we account for known risk factors, making them very valuable investment ideas.

MELA Sciences Inc (NASDAQ:MELA) has experienced a decrease in hedge fund sentiment of late. MELA was in 4 hedge funds’ portfolios at the end of September. There were 5 hedge funds in our database with MELA holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Wave Systems Corp. (NASDAQ:WAVX), Essex Rental Corp. (NASDAQ:ESSX), and Hooper Holmes, Inc. (NYSEMKT:HH) to gather more data points.

Follow Strata Skin Sciences Inc. (NASDAQ:SSKN)
Trade (NASDAQ:SSKN) Now!

Keeping this in mind, we’re going to analyze the recent action encompassing MELA Sciences Inc (NASDAQ:MELA).

What have hedge funds been doing with MELA Sciences Inc (NASDAQ:MELA)?

At the end of the third quarter, a total of 4 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -20% from the second quarter. With hedge funds’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were increasing their stakes significantly (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Broadfin Capital, managed by Kevin Kotler, holds the number one position in MELA Sciences Inc (NASDAQ:MELA). Broadfin Capital has a $1.5 million position in the stock, comprising 0.1% of its 13F portfolio. The second largest stake is held by Hal Mintz of Sabby Capital, with a $0.8 million position; less than 0.1% of its 13F portfolio is allocated to the stock. Other members of the smart money with similar optimism contain Ken Griffin’s Citadel Investment Group, Paul Orlin and Alex Porter’s Amici Capital.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!